Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.89 +0.01 (+0.09%)
At close: Oct 1, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition (DMAA) Shares Outstanding (Diluted) (2024 - 2026)

Updated

Drugs Made In America Acquisition's Shares Outstanding (Diluted) came in at 30.81 million for Q2 2026, down 8.1% from 33.52 million a year earlier.

Analysis

Drugs Made In America Acquisition (DMAA) Shares Outstanding (Diluted) (2024 - 2026) Analysis & Trends

For FY2025, Drugs Made In America Acquisition's Shares Outstanding (Diluted) was 31.64 million, up 269.1% from FY2024.

  • Going back by year, Shares Outstanding (Diluted) was 8.57 million in FY2024.
  • The Q2 2026 figure represents the lowest quarterly Shares Outstanding (Diluted) since Q1 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 BlackRock 164.13 Bn 110.49 Bn - 164.65 Mn
2 Spdr Gold Trust 133.82 Bn -424.18 Bn - -
3 Blackstone 84.08 Bn 79.01 Bn - 799.90 Mn
4 Brookfield 82.97 Bn -82.41 Bn 4.47 Bn 2.37 Bn
5 Kkr 81.05 Bn 47.53 Bn - 945.58 Mn
6 Brookfield Asset Management 71.64 Bn 67.88 Bn - 1.61 Bn
7 Apollo Global Management 65.67 Bn 3.35 Bn 10.56 Bn 610.22 Mn
8 Wheaton Precious Metals 61.89 Bn 57.32 Bn 687.86 Mn 454.69 Mn
9 Franco Nevada 46.13 Bn 43.49 Bn 451.00 Mn 193.00 Mn
10 Drugs Made In America Acquisition 335.55 Mn 335.55 Mn - 30.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30.81 Mn
Dec 31, 2025 31.64 Mn
Sep 30, 2025 33.52 Mn
Jun 30, 2025 33.52 Mn
Mar 31, 2025 25.51 Mn
Dec 31, 2024 8.57 Mn
API Access

Drugs Made In America Acquisition Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=DMAA&period=max&api_key=YOUR_API_KEY